Deutsche Börse just dropped its Q3 2026 scorecard and the headline is clear. Net revenue for the first nine months hit €4.9b and management lifted full year guidance again, leaning on what they describe as strong operating leverage. Yet the share price closed at €308, roughly flat over the past week, after a one day reaction that looked more like a shrug than a celebration.
The real flashpoint is valuation. A P/E of 25.2x and a modest discount to a discounted cash flow fair value estimate are pulling investor psychology in opposite directions, which helps explain why the stock's chart looks calm while the earnings story sounds punchy.
Love Deutsche Börse's hefty net revenue and operating leverage story but uneasy about paying a 25.2x P/E for it? Compare that premium with a 227 resilient stocks with low risk scores to see how other resilient businesses with lower risk scores line up.
Q3 2026 Earnings Summary
-
Revenue (Q3 2026 vs. Q3 2025):€2,069m vs. €1,776m (up about 16.5%)
-
Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025):€559m vs. €473m (up about 18.2%)
-
Basic EPS (Q3 2026 vs. Q3 2025):€3.10 vs. €2.59 (up about 19.9%)
-
Net Margin (Trailing 12 Months to Q3 2026 vs. Prior 12 Months):~27.4% vs. ~27.6% (slight decline)
Earnings tell you what Deutsche Börse reported this quarter, but investors who care about valuation often follow the cash moving through the business instead of just the accounting line. Based on Deutsche Börse's cash flows alone, the stock could be a modest 6% undervalued .
Deutsche Börse: Testing The Recurring Growth Story
The upbeat story says Deutsche Börse can lean more on sticky software and data income, not just trading swings.
"Ongoing expansion into higher margin recurring software and data services, reflected in double digit ARR growth in Software Solutions and a rising SaaS mix around SimCorp and ISS STOXX, is widening Deutsche Börse exposure to subscription style revenues and has the potential to further support earnings quality and EBITDA margins."
Q3 numbers back that up. Software Solutions net revenue rose 10%, ARR reached €727m with 13% constant currency growth and SaaS climbed 13%. Segment comments on ISS STOXX show some internal reshaping, yet the broader software and data engine is delivering the kind of recurring profile this thesis leans on.
Deutsche Börse: Stress Testing The Allfunds Risk
The main worry is whether Deutsche Börse can hold tight cost control while absorbing Allfunds.
"The Allfunds acquisition is expected to deliver €60 million of annual operating cost savings and €30 million of capex savings. However, if integration proves more complex than planned or synergy capture is delayed, Deutsche Börse may struggle to hold underlying cost growth near 3% and this would put pressure on EBITDA margins and earnings."
So far, evidence cuts against that concern. Management reported underlying operating expense growth around 3% excluding Allfunds related items and an EBITDA margin of 61% year to date. Guidance still targets €3.1b EBITDA excluding treasury, with Allfunds integration costs ring fenced, which keeps the operating leverage narrative intact for now.
That disagreement has a full argument behind it. → Uncover the lower Fair Value this Narrative argues for .
Hunt Quiet Disconnects In Plain Sight
Deutsche Börse just showed how a busy earnings story can coexist with a muted share price. The real opportunity is finding stocks that could be undervalued before the market corrects them.
-
Company 1 - 30% below our estimate - uses prosthetics, neuro orthotics, reimbursement gains and clinic upgrades to lift patient care services.
-
Company 2 - 34% below our estimate - replaces blast furnaces with electric arc technology to cut carbon costs and emphasize specialized steel products.
-
Company 3 - 40% below our estimate - builds solar tracking and control platforms that turn an expanding order backlog into recurring projects.
Three companies from the same screener. Open every one of the 190 undervalued companies on it →
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include DB1.DE .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
